Administration Efficacy/effectiveness Safety All age groups Influenza Pneumococcal disease
Administration Efficacy/effectiveness Safety Newborn (0-1 years) Hepatitis B Diphtheria Pertussis Tetanus Haemophilus influenzae type B Poliomyelitis
Efficacy/effectiveness Safety Administration All age groups Haemophilus influenzae type B
Efficacy/effectiveness Safety Administration Adults (18+) Elderly (65+) Influenza Pneumococcal disease
Coverage Ethical issues Elderly (65+) Influenza Pneumococcal disease
Economic aspects Newborn (0-1 years) Children (2-9 years) Haemophilus influenzae type B
Economic aspects Newborn (0-1 years) Children (2-9 years) Haemophilus influenzae type B
Efficacy/effectiveness Safety Adults (18+) Elderly (65+) Haemophilus influenzae type B
Coverage Ethical issues Elderly (65+) Influenza Pneumococcal disease
Economic aspects All age groups Influenza Rotavirus Meningococcal disease Pneumococcal disease Hepatitis B Varicella